Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.6 HKD | +1.69% | +6.08% | -6.80% |
03-26 | Mega Genomics Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-12 | Mega Genomics Stockholders to Vote March 1 on Continuing Transactions | MT |
Sales 2021 | 237M 32.76M 256M 44.98M | Sales 2022 | 146M 20.13M 157M 27.64M | Capitalization | 2.75B 379M 2.97B 521M |
---|---|---|---|---|---|
Net income 2021 | 79M 10.91M 85.34M 14.98M | Net income 2022 | -17M -2.35M -18.36M -3.22M | EV / Sales 2021 * | - |
Net cash position 2021 | 451M 62.3M 487M 85.55M | Net cash position 2022 | 398M 54.91M 429M 75.4M | EV / Sales 2022 | 16.1 x |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-128
x | Employees | 229 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 51.86% |
1 day | +1.69% | ||
1 week | +6.08% | ||
Current month | -4.19% | ||
1 month | +14.29% | ||
3 months | +9.22% | ||
6 months | +21.83% | ||
Current year | -6.80% |
Managers | Title | Age | Since |
---|---|---|---|
Jing Jiang
CEO | Chief Executive Officer | 44 | - |
Xiang Yi
CTO | Chief Tech/Sci/R&D Officer | 44 | - |
Xia An
COO | Chief Operating Officer | 41 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rong Yu
FOU | Founder | 52 | 21-04-21 |
Mei Ling Guo
BRD | Director/Board Member | 54 | 21-08-05 |
Lin Lin
CHM | Chairman | 48 | 21-04-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 9.6 | +1.69% | 30 200 |
24-04-30 | 9.44 | +3.17% | 18,200 |
24-04-29 | 9.15 | +0.55% | 17,600 |
24-04-26 | 9.1 | -0.55% | 4,000 |
24-04-25 | 9.15 | -0.22% | 12,400 |
Delayed Quote Hong Kong S.E., May 01, 2024 at 09:58 pm
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.80% | 286M | |
-18.49% | 8.35B | |
+45.10% | 3.58B | |
-8.06% | 2.47B | |
-38.71% | 2.46B | |
-7.96% | 2.36B | |
-13.72% | 1.78B | |
-19.73% | 1.53B | |
-40.78% | 1.21B | |
+8.32% | 1.12B |
- Stock Market
- Equities
- 6667 Stock